Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates clonal diversity of MYC promotes metastasis and angiogenesis in medulloblastoma, suggesting targeting secretome signaling can halt tumor progression.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: